Authors
Loading...
bcl-2 expression suggests neuroprotection in developing neurons; leaves open therapeutic targeting in CNS disorders.
Key points are not available for this paper at this time.
Merry et al. (1994) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: